Stocks
GlaxoSmithKline (GSK) OPEX US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| OPEX, £ | 13 337 000 000 | 15 377 000 000 | 15 018 000 000 | 18 307 000 000 | 15 312 000 000 | 15 410 000 000 | |||
| Changes by years, y/y, % | 0% | +15% | -2% | +22% | -16% | +0.9% | |||
GlaxoSmithKline. OPEX, £
GlaxoSmithKline. OPEX, changes, %
GlaxoSmithKline. OPEX, sum by quarters, £
GlaxoSmithKline (GSK) OPEX US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| OPEX, £ | 3 363 000 000 | 3 798 000 000 | 3 696 000 000 | 4 455 000 000 | 3 461 000 000 | 15 410 000 000 | ||
| Changes by years, y/y, % | -2% | -1% | -32% | -8% | +3% | |||
| Changes by quarters, q/q, % | -31% | +13% | -3% | +21% | -22% | |||
